Differential (Click to cross reference) advances in neurology adverse drug reaction algorithm andexanet antiarrhythmic drugs anticoagulant, complications of anticoagulant, contraindications anticoagulant, discontinuation anticoagulant, restarting anticoagulant, reversal of anticoagulant, treatment anticoagulant, treatment in CVD anticoagulation effect anticoagulation, perioperative apixaban argatroban arrhythmia, cardiac aspirin asymptomatic atrial appendage closure atrial fibrillation atrial fibrillation, nonvalvular atrial fibrillation, risk stratification atrial fibrillation, surgical treatment atrial fibrillation, treatment atrial flutter atrial septal defect bedridden breast feeding bridge therapy bronchoscopy cancer associated hypercoagulation cancer, cerebrovascular accident complicating patients with carcinoma cardiomyopathy carotid artery occlusion, intracranial carotid artery occlusion, perioperative CAT scan, abnormal cataract surgery cerebral embolism cerebral embolism, cardiac origin cerebral embolism, mechanical extraction cerebral infarction cerebral venous thrombosis cerebrovascular accident cerebrovascular accident, acute management of cerebrovascular accident, cardiac disease causing cerebrovascular accident, complications with cerebrovascular accident, cryptogenic cerebrovascular accident, postoperative cerebrovascular accident, prevention of cerebrovascular accident, primary prevention cerebrovascular accident, recurrent cerebrovascular accident, secondary prevention cerebrovascular accident, severity cerebrovascular accident, thrombolytic agents in treatment cerebrovascular accident, women cerebrovascular accident, young adult CHADS-VaSC score ciraparantag clopidogrel clot retrieval colonoscopy compliance complications controversies in neurology cost cost effectiveness coumarin coumarin, restarting treatment coumarin, stopping treatment cryoablation dabigatran dabigatran, dose deafness, unilateral delivery, complicated dental procedure, neurologic complications with dialysis drug interactions dural sinus thrombosis dyspepsia edoxaban efficacy electromyogram embolic stroke of unknown source embolism, systemic endoscopic surgery endoscopy endovascular therapy enoxaparin evidence-based research factor Xa inhibitor falling fibrinolytic agents fibrinolytic agents, complications fibrinolytic agents, contraindications fibrinolytic agents, intra-arterial local infusion fibrinolytic therapy, selection criteria gastrointestinal bleeding HAS-BLED score head injury headache heart valve, prosthetic hemorrhagic diathesis hemostatic therapy heparin heparin, low-molecular-weight heparinoid, low molecular weight hepatic failure hip arthroplasty Holter monitoring hormone replacement hormone therapy iatrogenic neurologic disorders idarucizumab incidental finding INR value, time in range INR values intracerebral hemorrhage intracerebral hemorrhage, progression of intracerebral hemorrhage, silent intracerebral hemorrhage, treatment of intracerebral hemorrhage, volume intracranial hemorrhage labor, complicated left atrial appendage, percutaneous closure left ventricular dysfunction liver disease liver function enzymes menopause MERCI trial microhemorrhage, intracerebral middle cerebral artery, occlusion of mimics misdiagnosis mortality MRI, abnormal myocardial infarction neurologic complications of, surgery neuroradiology, interventional NIH stroke scale non-vitamin K antagonist oral anticoagulants non-vitamin K antagonist oral anticoagulants, coagulation test number needed to treat old age, neurology of oral contraceptives oral contraceptives, cerbrovascular disease and ovarian induction pacemaker, cardiac-transvenous partial thromboplastin time patent foramen ovale, surgical treatment of patient information and support peri-procedural platelet inhibiting drugs platelet inhibiting drugs, combined platelet inhibiting drugs, discontinuation postoperative neurologic complications practice guidelines pregnancy, neurologic complications in prevention of neurologic disorders prognosis prothrombin complex concentrate prothrombin time prothrombin time, prolonged radiofrequency ablation rapid thromboelasticity recanalization, arterial recurrent RELY trial renal failure reperfusion RESPECT trial review article risk factors risk factors, modification risk stratification risk-benefit assessment rivaroxaban ROCKET - AF trial safety serum alanine aminotransferase solitaire device SPORTIF trial stent, carotid artery subarachnoid hemorrhage subarachnoid hemorrhage, cerebral convexity subdural hematoma T lesion of MCA-ICA teratogenesis teratogenic drugs thrombectomy thrombin inhibitor thrombolysis, mechanical thrombophlebitis thrombus, mural tissue plasminogen activator, intravenous transient ischemic attack transient neurologic deficit transluminal angioplasty, coronary artery transurethral prostatectomy trauma treatment of neurologic disorder venous thrombosis, non-cerebral vitamin K vitamin K antagonist Watchman device ximelagatran

Showing articles 850 to 865 of 865 << Previous Postural Hypotension:Adrenergic Responsivity, & Levodopa Therapy Neurol 27:921, Corder,C.N.,et al, 1977 A Syndrome of Early Recognition of Occult Hydrocephalus & Cerebral Atrophy Quart J Med 183:365, Botez,M.I.,et al, 1977 Diffuse"Anoxic"Myelopathy Neurol 27:1049, Azzarelli,B.,et al, 1977 Drug Therapy of Parkinsonism NEJM 295:814, Bianchine,J.R., 1976 Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease NEJM 293:174, Genton,E.,et al, 1975 Neuropharmacological Aspects of Migraine Editorial, BMJ 339, 1975, Aug., , 1975 Neurotoxicity of Commonly Used Antineoplastic Agents NEJM 291:75, 1271974., Weiss,H.,et al, 1974 Post-Herpes Zoster Neuralgia:Response to Vitamin E Therapy Arch Dermatol 108:855, Ayres,S.Jr.,et al, 1973 The Treatment of Cerebrovascular Disease with Clofibrate VA Cooperative Study Group, Stroke 4:6841973., , 1973 Muscular Syndrome after Clofibrate NEJM 286:1110, Katsilambros,N., 1972 Clofibrate for the Treatment of Occlusive CVD-Correspondence NEJM 287:671, Hirsch,S.,et al, 1972 Drug Therapy of Parkinsonism NEJM 287:20, Yahr,M.,et al, 1972 Effect of Chronic Anticonvulsant Therapy on Serum 25-Hydroxycalciferol Levels in Adults NEJM 287:898, Hahn,T.,et al, 1972 Hypokalemic Periodic Paralysis withArrhythmia NEJM 286:253, Levitt,L.,et al, 1972 Monoamine Oxidase Inhibitor & L-Dopa BMJ 3:388, Hunter,H.R.,et al, 1970 Neuropsychopharmcology & the Affective Disorders NEJM 281:197, 1969 (three parts) ., Schildkraut,J.J., 1969 Showing articles 850 to 865 of 865 << Previous